Market research
068760.KO Celltrion Pharm Inc
KO KRW Not available
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- Not available
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- nan%
- Beta
- Not available
Community
Investor discussion
1 comment
Sign in to join the 068760.KO discussion.
5 years, 5 months ago
Celltrion Pharm Inc is currently in a long term uptrend where the price is trading 3.7% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Other sector with a price to sales ratio of 0.0.
Celltrion Pharm Inc's total revenue rose by 72.3% to $77B since the same quarter in the previous year.
Its net income has increased by 153.0% to $11B since the same quarter in the previous year.
Finally, its free cash flow grew by 11.4% to $6B since the same quarter in the previous year.
Based on the above factors, Celltrion Pharm Inc gets an overall score of 5/5.